BRCA-diagnostic

BRCA-diagnostic identifies mutations in BRCA1 and BRCA2 from whole genome sequencing (WGS) data to detect known pathogenic variants implicated in hereditary breast and ovarian cancer.

Key Features:

• BRCA1 and BRCA2 mutation identification: Detects mutations within BRCA1 and BRCA2 using whole genome sequencing (WGS) data.
• Whole Genome Sequencing integration: Leverages WGS to enable identification of both known and potentially novel variants across the genome.
• Algorithmic analysis: Applies advanced computational algorithms to analyze WGS data for systematic variant identification.

Scientific Applications:

• Genetic screening: Supports genetic screening programs to identify individuals at increased risk for hereditary breast and ovarian cancer by detecting BRCA1 and BRCA2 mutations.
• Research utility: Enables research on cancer susceptibility, including studies of gene-environment interactions and mutation impacts, using BRCA-focused variant data from WGS.

Methodology:

Employs advanced algorithms to analyze whole genome sequencing (WGS) data and systematically identify mutations within the BRCA1 and BRCA2 genes.